Stefan Plaum

520 total citations · 1 hit paper
15 papers, 344 citations indexed

About

Stefan Plaum is a scholar working on Dermatology, Epidemiology and Cell Biology. According to data from OpenAlex, Stefan Plaum has authored 15 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Dermatology, 8 papers in Epidemiology and 4 papers in Cell Biology. Recurrent topics in Stefan Plaum's work include Nail Diseases and Treatments (8 papers), Dermatology and Skin Diseases (7 papers) and Plant Pathogens and Fungal Diseases (4 papers). Stefan Plaum is often cited by papers focused on Nail Diseases and Treatments (8 papers), Dermatology and Skin Diseases (7 papers) and Plant Pathogens and Fungal Diseases (4 papers). Stefan Plaum collaborates with scholars based in United States, Germany and France. Stefan Plaum's co-authors include Gil Yosipovitch, Neil M.H. Graham, Marius Ardeleanu, Gianluca Pirozzi, Laurent Eckert, A. Gadkari, Nicole Williams, Heribert Staudinger, Matthew Reaney and M. Clark and has published in prestigious journals such as SHILAP Revista de lepidopterología, Antimicrobial Agents and Chemotherapy and Journal of the American Academy of Dermatology.

In The Last Decade

Stefan Plaum

15 papers receiving 341 citations

Hit Papers

Peak Pruritus Numerical Rating Scale: psychometric valida... 2019 2026 2021 2023 2019 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefan Plaum United States 7 260 181 113 69 42 15 344
Josefine Bandier Denmark 7 270 1.0× 156 0.9× 54 0.5× 32 0.5× 15 0.4× 10 326
Marco Ramírez-Gama United States 4 246 0.9× 156 0.9× 48 0.4× 27 0.4× 28 0.7× 8 315
Ann Broberg Sweden 9 366 1.4× 267 1.5× 114 1.0× 116 1.7× 19 0.5× 14 472
Suzana Ljubojević Hadžavdić Croatia 11 373 1.4× 180 1.0× 75 0.7× 43 0.6× 28 0.7× 50 476
S. Brinton United States 5 207 0.8× 96 0.5× 33 0.3× 31 0.4× 15 0.4× 6 295
Line Brok Nørreslet Denmark 11 293 1.1× 183 1.0× 73 0.6× 18 0.3× 28 0.7× 25 338
Riana Dutt United States 7 339 1.3× 259 1.4× 125 1.1× 19 0.3× 56 1.3× 8 399
P. M. J. H. Kemperman Netherlands 6 443 1.7× 246 1.4× 76 0.7× 40 0.6× 32 0.8× 16 582
Junko Arikawa Japan 6 249 1.0× 114 0.6× 49 0.4× 35 0.5× 22 0.5× 9 366
Jeremiah Miller United States 6 166 0.6× 63 0.3× 50 0.4× 56 0.8× 19 0.5× 6 301

Countries citing papers authored by Stefan Plaum

Since Specialization
Citations

This map shows the geographic impact of Stefan Plaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Plaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Plaum more than expected).

Fields of papers citing papers by Stefan Plaum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Plaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Plaum. The network helps show where Stefan Plaum may publish in the future.

Co-authorship network of co-authors of Stefan Plaum

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Plaum. A scholar is included among the top collaborators of Stefan Plaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Plaum. Stefan Plaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Marović, Ivan, Tomáš Hanák, & Stefan Plaum. (2022). PERFORMANCE MANAGEMENT IN CIVIL ENGINEERING: A SYSTEMATIC LITERATURE REVIEW. SHILAP Revista de lepidopterología. 13(24). 47–58. 4 indexed citations
2.
Beck, Lisa A., Jonathan I. Silverberg, Eric L. Simpson, et al.. (2020). Dupilumab significantly improves sleep outcomes in adult patients with atopic dermatitis: results from five randomized clinical trials. Journal of the European Academy of Dermatology and Venereology. 35(2). e130–e133. 9 indexed citations
3.
Yosipovitch, Gil, Matthew Reaney, Vera Mastey, et al.. (2019). Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate‐to‐severe atopic dermatitis. British Journal of Dermatology. 181(4). 761–769. 231 indexed citations breakdown →
4.
Yosipovitch, Gil, Matthew Reaney, Vera Mastey, et al.. (2019). Validation of the Peak Pruritus Numerical Rating Scale. British Journal of Dermatology. 181(4). 1 indexed citations
5.
Yosipovitch, Gil, Laurent Eckert, Marius Ardeleanu, et al.. (2017). P480 Correlations of itch with quality of life and signs of atopic dermatitis across dupilumab trials. Annals of Allergy Asthma & Immunology. 119(5). S95–S95. 5 indexed citations
6.
Silverberg, Jonathan I., J. Chao, Laurent Eckert, et al.. (2017). P481 Dupilumab treatment rapidly improves itch in patients with moderate-to-severe atopic dermatitis. Annals of Allergy Asthma & Immunology. 119(5). S95–S95. 2 indexed citations
7.
Bruin‐Weller, Marjolein de, A. Gadkari, Eric L. Simpson, et al.. (2017). P479 Dupilumab improves patient-reported outcomes in atopic dermatitis patients inadequately controlled, intolerant, or inadvisable for cyclosporine-A. Annals of Allergy Asthma & Immunology. 119(5). S94–S95. 2 indexed citations
8.
Ghannoum, Mahmoud A., et al.. (2013). In Vitro Antifungal Activity of Naftifine Hydrochloride against Dermatophytes. Antimicrobial Agents and Chemotherapy. 57(9). 4369–4372. 30 indexed citations
9.
Plaum, Stefan, et al.. (2013). Detection and relevance of naftifine hydrochloride in the stratum corneum up to four weeks following the last application of naftifine cream and gel, 2%.. PubMed. 12(9). 1004–8. 8 indexed citations
10.
Vlahovic, Tracey C., et al.. (2013). Efficacy and safety of naftifine HCl Gel 2% in the treatment of interdigital and moccasin type tinea pedis: pooled results from two multicenter, randomized, double-blind, vehicle-controlled trials.. PubMed. 12(8). 911–8. 6 indexed citations
11.
Draelos, Zoé Kececioglu, et al.. (2012). A new proprietary onion extract gel improves the appearance of new scars: a randomized, controlled, blinded-investigator study.. PubMed. 5(6). 18–24. 19 indexed citations
12.
Gold, Michael H., et al.. (2012). An open-label pilot study of naftifine 1% gel in the treatment of seborrheic dermatitis of the scalp.. PubMed. 11(4). 514–8. 3 indexed citations
13.
Parish, Lawrence Charles, et al.. (2011). A randomized, double-blind, vehicle-controlled efficacy and safety study of naftifine 2% cream in the treatment of tinea pedis.. PubMed. 10(11). 1282–8. 10 indexed citations
14.
Gold, Michael H., Tancy M Bridges, Stefan Plaum, et al.. (2011). An open-label study of naftifine hydrochloride 1% gel in the treatment of tinea versicolor. Journal of the American Academy of Dermatology. 64(2). AB106–AB106. 6 indexed citations
15.
Parish, Lawrence Charles, et al.. (2011). A double-blind, randomized, vehicle-controlled study evaluating the efficacy and safety of naftifine 2% cream in tinea cruris.. PubMed. 10(10). 1142–7. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026